GLKClass II
Control, Hematocrit
21 CFR 864.8625 / Hematology
GLK is the FDA product code for Control, Hematocrit, a class II device type, regulated under 21 CFR 864.8625. As of , FDA records hold 7 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- GLK
- Device name
- Control, Hematocrit
- Regulation
- 21 CFR 864.8625
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 7
- Ingested recalls
- 0
Clearances, product code GLK
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1989 | 1 |
| 1993 | 1 |
| 1996 | 1 |
| 1997 | 1 |
| 2002 | 2 |
| 2013 | 1 |
Applicants with the most clearances
Product code GLK| Applicant | Clearances |
|---|---|
| Aalto Scientific Ltd. | 1 |
| Bionostics, Inc. | 1 |
| Ciba Corning Diagnostics Corp. | 1 |
| Eurotrol B.V. | 1 |
| Johnson & Johnson Professionals, Inc. | 1 |
| Medical Specialties Inc. | 1 |
| Richmond Diagnostics, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
